TY - JOUR AU - Lincoln, T. M. AU - Cornwell, T. L. PY - 1993 DA - 1993// TI - Intracellular cyclic GMP receptor proteins JO - FASEB J VL - 7 ID - Lincoln1993 ER - TY - JOUR AU - Corbin, J. D. AU - FRANCIS, S. H. PY - 1999 DA - 1999// TI - Cyclic GMP phosphodiesterase-5: target of Sildenafil JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.20.13729 DO - 10.1074/jbc.274.20.13729 ID - Corbin1999 ER - TY - JOUR AU - Baltrons, M. A. AU - Pedraza, C. AU - Sardón, T. AU - Navarra, M. AU - García, A. PY - 2003 DA - 2003// TI - Regulation of NO-dependent cyclic GMP formation by inflammatory agents in neural cells JO - Toxicol Lett VL - 139 UR - https://doi.org/10.1016/S0378-4274(02)00433-2 DO - 10.1016/S0378-4274(02)00433-2 ID - Baltrons2003 ER - TY - JOUR AU - Nunes, A. K. AU - Rapôso, C. AU - Luna, R. L. AU - Cruz-Höfling, M. A. AU - Peixoto, C. A. PY - 2012 DA - 2012// TI - Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model JO - Cytokine VL - 60 UR - https://doi.org/10.1016/j.cyto.2012.06.011 DO - 10.1016/j.cyto.2012.06.011 ID - Nunes2012 ER - TY - STD TI - Raposo C, Nunes AK, Luna RL, Araújo SM, da Cruz-Höfling MA, Peixoto CA. Sildenafil (Viagra) protective effects on neuroinflammation: the role of iNOS/NO system in an inflammatory demyelination model. Mediators Inflamm. 2013;321460. ID - ref5 ER - TY - JOUR AU - Shenoy, P. AU - Agarwal, V. PY - 2010 DA - 2010// TI - Phosphodiesterase inhibitors in the management of autoimmune disease JO - Autoimmun Rev VL - 9 UR - https://doi.org/10.1016/j.autrev.2010.02.012 DO - 10.1016/j.autrev.2010.02.012 ID - Shenoy2010 ER - TY - JOUR AU - Keravis, T. AU - Lugnier, C. PY - 2012 DA - 2012// TI - Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments JO - Br J Pharmacol VL - 5 UR - https://doi.org/10.1111/j.1476-5381.2011.01729.x DO - 10.1111/j.1476-5381.2011.01729.x ID - Keravis2012 ER - TY - JOUR AU - Uckert, S. AU - Hedlund, P. AU - Andersson, K. E. AU - Truss, M. C. AU - Jonas, U. AU - Stief, C. G. PY - 2006 DA - 2006// TI - Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future JO - Eur Urol VL - 50 UR - https://doi.org/10.1016/j.eururo.2006.05.025 DO - 10.1016/j.eururo.2006.05.025 ID - Uckert2006 ER - TY - JOUR AU - Chung, K. F. PY - 2006 DA - 2006// TI - Phosphodiesterase inhibitors in airways disease JO - Eur J Pharmacol VL - 533 UR - https://doi.org/10.1016/j.ejphar.2005.12.059 DO - 10.1016/j.ejphar.2005.12.059 ID - Chung2006 ER - TY - JOUR AU - Essayan, D. M. PY - 1999 DA - 1999// TI - Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation JO - Biochem Pharmacol VL - 57 UR - https://doi.org/10.1016/S0006-2952(98)00331-1 DO - 10.1016/S0006-2952(98)00331-1 ID - Essayan1999 ER - TY - JOUR AU - Boolell, M. AU - Allen, M. J. AU - Ballard, S. A. AU - Gepi-Attee, S. AU - Muirhead, G. J. AU - Naylor, A. M. PY - 1996 DA - 1996// TI - Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction JO - Int J Impot Res VL - 8 ID - Boolell1996 ER - TY - JOUR AU - Galiè, N. AU - Ghofrani, H. A. AU - Torbicki, A. AU - Barst, R. J. AU - Rubin, L. J. AU - Badesch, D. PY - 2005 DA - 2005// TI - Sildenafil citrate therapy for pulmonary arterial hypertension JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa050010 DO - 10.1056/NEJMoa050010 ID - Galiè2005 ER - TY - JOUR AU - Galiè, N. AU - Brundage, B. H. AU - Ghofrani, H. A. AU - Oudiz, R. J. AU - Simonneau, G. AU - Safdar, Z. PY - 2009 DA - 2009// TI - Tadalafil therapy for pulmonary arterial hypertension JO - Circulation VL - 119 UR - https://doi.org/10.1161/CIRCULATIONAHA.108.839274 DO - 10.1161/CIRCULATIONAHA.108.839274 ID - Galiè2009 ER - TY - JOUR AU - Roustit, M. AU - Hellmann, M. AU - Cracowski, C. AU - Blaise, S. AU - Cracowski, J. L. PY - 2012 DA - 2012// TI - Sildenafil increases digital skin blood flow during all phases of local cooling in primary Raynaud’s phenomenon JO - Clin Pharmacol Ther VL - 91 UR - https://doi.org/10.1038/clpt.2011.302 DO - 10.1038/clpt.2011.302 ID - Roustit2012 ER - TY - JOUR AU - Zhu, J. AU - Mix, E. AU - Winblad, B. PY - 2001 DA - 2001// TI - The antidepressant and anti-inflammatory effects of rolipram in the central nervous system JO - CNS Drug Rev VL - 7 UR - https://doi.org/10.1111/j.1527-3458.2001.tb00206.x DO - 10.1111/j.1527-3458.2001.tb00206.x ID - Zhu2001 ER - TY - JOUR AU - Benjamins, J. A. AU - Nedelkoska, L. PY - 2007 DA - 2007// TI - Cyclic GMP-dependent pathways protect differentiated oligodendrocytes form multiple types of injury JO - Neurochem Res VL - 32 UR - https://doi.org/10.1007/s11064-006-9187-7 DO - 10.1007/s11064-006-9187-7 ID - Benjamins2007 ER - TY - JOUR AU - Zhao, S. AU - Zhang, L. AU - Lian, G. AU - Wang, X. AU - Zhang, H. AU - Yao, X. PY - 2011 DA - 2011// TI - Sildenafil attenuates LPS-induced pro-inflammatory responses through down-regulation of intracellular ROS-related MAPK/NF-ΚB signaling pathways in n9 microglia JO - Int Immunopharmacol VL - 11 UR - https://doi.org/10.1016/j.intimp.2010.12.017 DO - 10.1016/j.intimp.2010.12.017 ID - Zhao2011 ER - TY - JOUR AU - Khoshakhlagh, P. AU - Bahrololoumi-Shapourabadi, M. AU - Mohammadirad, A. AU - Ashtaral-Nakhai, L. AU - Minaie, B. AU - Abdollahi, M. PY - 2007 DA - 2007// TI - Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; molecular evidence for involvement of oxidative stress JO - Toxicol Mech Methods VL - 17 UR - https://doi.org/10.1080/15376510601003769 DO - 10.1080/15376510601003769 ID - Khoshakhlagh2007 ER - TY - JOUR AU - Titus, D. J. AU - Oliva, A. A. AU - Wilson, N. M. AU - Atkins, C. M. PY - 2014 DA - 2014// TI - Phosphodiesterase inhibitors as therapeutics for traumatic brain injury JO - Curr Pharm Des VL - 21 UR - https://doi.org/10.2174/1381612820666140826113731 DO - 10.2174/1381612820666140826113731 ID - Titus2014 ER - TY - JOUR AU - Grimsley, S. J. AU - Khan, M. H. AU - Jones, G. E. PY - 2007 DA - 2007// TI - Mechanism of Phosphodiesterase 5 inhibitor relief of prostatitis symptoms JO - Med Hypotheses VL - 69 UR - https://doi.org/10.1016/j.mehy.2006.11.040 DO - 10.1016/j.mehy.2006.11.040 ID - Grimsley2007 ER - TY - JOUR AU - Delledonne, M. AU - Polverari, A. AU - Murgia, I. PY - 2003 DA - 2003// TI - The functions of nitric oxide-mediated signaling and changes in gene expression during the hypersensitive response JO - Antioxid Redox Signal VL - 5 UR - https://doi.org/10.1089/152308603321223522 DO - 10.1089/152308603321223522 ID - Delledonne2003 ER - TY - JOUR AU - Palmer, A. C. AU - Calder, I. M. AU - Hughes, J. T. PY - 1987 DA - 1987// TI - Spinal cord degeneration in divers JO - Lancet VL - 2 UR - https://doi.org/10.1016/S0140-6736(87)91259-1 DO - 10.1016/S0140-6736(87)91259-1 ID - Palmer1987 ER - TY - JOUR AU - Garthwaite, G. AU - Garthwaite, J. PY - 1988 DA - 1988// TI - Cyclic GMP and cell death in rat cerebellar slices JO - Neuroscience VL - 26 UR - https://doi.org/10.1016/0306-4522(88)90148-0 DO - 10.1016/0306-4522(88)90148-0 ID - Garthwaite1988 ER - TY - JOUR AU - Knowles, R. G. AU - Palacios, M. AU - Palmer, R. M. AU - Moncada, S. PY - 1989 DA - 1989// TI - Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase JO - Proc Natl Acad Sci U S A VL - 86 UR - https://doi.org/10.1073/pnas.86.13.5159 DO - 10.1073/pnas.86.13.5159 ID - Knowles1989 ER - TY - JOUR AU - Esplugues, J. V. PY - 2002 DA - 2002// TI - NO as a signalling molecule in the nervous system JO - Br J Pharmacol VL - 135 UR - https://doi.org/10.1038/sj.bjp.0704569 DO - 10.1038/sj.bjp.0704569 ID - Esplugues2002 ER - TY - JOUR AU - Stuehr, D. J. AU - Nathan, C. F. PY - 1989 DA - 1989// TI - Nitric oxide - a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells JO - J Exp Med VL - 169 UR - https://doi.org/10.1084/jem.169.5.1543 DO - 10.1084/jem.169.5.1543 ID - Stuehr1989 ER - TY - JOUR AU - Aranda, E. AU - López-Pedrera, C. AU - Haba-Rodriguez, J. R. AU - Rodriguez-Ariza, A. PY - 2012 DA - 2012// TI - Nitric oxide and cancer: the emerging role of S-nitrosylation JO - Curr Mol Med VL - 12 UR - https://doi.org/10.2174/156652412798376099 DO - 10.2174/156652412798376099 ID - Aranda2012 ER - TY - JOUR AU - Rizzo, M. AU - Kotur-Stevuljevic, J. AU - Berneis, K. AU - Spinas, G. AU - Rini, G. B. AU - Jelic-Ivanovic, Z. PY - 2009 DA - 2009// TI - Atherogenic dyslipidemia and oxidative stress: a new look JO - Transl Res VL - 153 UR - https://doi.org/10.1016/j.trsl.2009.01.008 DO - 10.1016/j.trsl.2009.01.008 ID - Rizzo2009 ER - TY - JOUR AU - Spiecker, M. AU - Peng, H. B. AU - Liao, J. K. PY - 1997 DA - 1997// TI - Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.49.30969 DO - 10.1074/jbc.272.49.30969 ID - Spiecker1997 ER - TY - JOUR AU - Aizawa, T. AU - Wei, H. AU - Miano, J. M. AU - Abe, J. AU - Berk, B. C. AU - Yan, C. PY - 2003 DA - 2003// TI - Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells JO - Circ Res VL - 93 UR - https://doi.org/10.1161/01.RES.0000091074.33584.F0 DO - 10.1161/01.RES.0000091074.33584.F0 ID - Aizawa2003 ER - TY - JOUR AU - Zhang, J. AU - Xie, Z. AU - Dong, Y. AU - Wang, S. AU - Liu, C. AU - Zou, M. H. PY - 2008 DA - 2008// TI - Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells JO - J Biol Chem VL - 283 UR - https://doi.org/10.1074/jbc.M802578200 DO - 10.1074/jbc.M802578200 ID - Zhang2008 ER - TY - JOUR AU - Yuan, Z. AU - Hein, T. W. AU - Rosa, R. H. AU - Kuo, L. PY - 2008 DA - 2008// TI - Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition JO - Invest Ophthalmol Vis Sci VL - 49 UR - https://doi.org/10.1167/iovs.07-1208 DO - 10.1167/iovs.07-1208 ID - Yuan2008 ER - TY - JOUR AU - Mammi, C. AU - Pastore, D. AU - Lombardo, M. F. AU - Ferrelli, F. AU - Caprio, M. AU - Consoli, C. PY - 2011 DA - 2011// TI - Sildenafil reduces insulin-resistance in human endothelial cells JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0014542 DO - 10.1371/journal.pone.0014542 ID - Mammi2011 ER - TY - JOUR AU - Fisher, P. W. AU - Salloum, F. AU - Das, A. AU - Hyder, H. AU - Kukreja, R. C. PY - 2005 DA - 2005// TI - Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity JO - Circulation VL - 111 UR - https://doi.org/10.1161/01.CIR.0000160359.49478.C2 DO - 10.1161/01.CIR.0000160359.49478.C2 ID - Fisher2005 ER - TY - JOUR AU - DeSouza, C. AU - Parulkar, A. AU - Lumpkin, D. AU - Akers, D. AU - Fonseca, D. A. PY - 2002 DA - 2002// TI - Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes JO - Diabetes Care VL - 25 UR - https://doi.org/10.2337/diacare.25.8.1336 DO - 10.2337/diacare.25.8.1336 ID - DeSouza2002 ER - TY - JOUR AU - Aversa, A. AU - Vitale, C. AU - Volterrani, M. AU - Fabbri, A. AU - Spera, G. AU - Fini, M. PY - 2008 DA - 2008// TI - Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes JO - Diabet Med VL - 25 UR - https://doi.org/10.1111/j.1464-5491.2007.02298.x DO - 10.1111/j.1464-5491.2007.02298.x ID - Aversa2008 ER - TY - JOUR AU - Milani, E. AU - Nikfar, S. AU - Khorasani, R. AU - Zamani, M. J. AU - Mohammad, A. PY - 2005 DA - 2005// TI - Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats JO - Biochem Physiol C Toxicol Pharmacol VL - 140 UR - https://doi.org/10.1016/j.cca.2005.02.010 DO - 10.1016/j.cca.2005.02.010 ID - Milani2005 ER - TY - JOUR AU - Shukla, N. AU - Jones, R. AU - Persad, R. AU - Angelini, G. D. AU - Jeremy, J. Y. PY - 2005 DA - 2005// TI - Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits JO - Eur J Pharmacol VL - 517 UR - https://doi.org/10.1016/j.ejphar.2005.05.012 DO - 10.1016/j.ejphar.2005.05.012 ID - Shukla2005 ER - TY - JOUR AU - Balarini, C. M. AU - Leal, M. A. AU - Gomes, I. B. AU - Pereira, T. M. AU - Gava, A. L. AU - Meyrelles, S. S. PY - 2013 DA - 2013// TI - Sildenafil restores endothelial function in the apolipoprotein E knockout mouse JO - J Transl Med VL - 11 UR - https://doi.org/10.1186/1479-5876-11-3 DO - 10.1186/1479-5876-11-3 ID - Balarini2013 ER - TY - JOUR AU - Bogdan, S. AU - Seferian, A. AU - Totoescu, A. AU - Dumitrache-Rujinski, S. AU - Ceausu, M. AU - Coman, C. PY - 2012 DA - 2012// TI - Sildenafil reduces inflammation and prevents pulmonary arterial remodeling of the monocrotaline - induced disease in the Wistar rats JO - Maedica (Buchar) VL - 7 ID - Bogdan2012 ER - TY - JOUR AU - Margonis, G. A. AU - Christoloukas, N. AU - Antoniou, E. AU - Arkadopoulos, N. AU - Theodoropoulos, G. AU - Agrogiannis, G. PY - 2015 DA - 2015// TI - Effectiveness of sildenafil and U-74389G in a rat model of colitis JO - J Surg Res VL - 193 UR - https://doi.org/10.1016/j.jss.2014.08.064 DO - 10.1016/j.jss.2014.08.064 ID - Margonis2015 ER - TY - JOUR AU - Salari, P. AU - Abdollahi, M. PY - 2012 DA - 2012// TI - Phosphodiesterase inhibitors in inflammatory bowel disease JO - Expert Opin Investig Drugs VL - 21 UR - https://doi.org/10.1517/13543784.2012.658915 DO - 10.1517/13543784.2012.658915 ID - Salari2012 ER - TY - JOUR AU - Cadirci, E. AU - Halici, Z. AU - Odabasoglu, F. AU - Albayrak, A. AU - Karakus, E. AU - Unal, D. PY - 2011 DA - 2011// TI - Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study JO - Clin Exp Immunol VL - 166 UR - https://doi.org/10.1111/j.1365-2249.2011.04483.x DO - 10.1111/j.1365-2249.2011.04483.x ID - Cadirci2011 ER - TY - JOUR AU - Li, N. AU - Xi, Y. AU - Tinsley, H. N. AU - Gurpinar, E. AU - Gary, B. D. AU - Zhu, B. PY - 2013 DA - 2013// TI - Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling JO - Mol Cancer Ther VL - 12 UR - https://doi.org/10.1158/1535-7163.MCT-13-0048 DO - 10.1158/1535-7163.MCT-13-0048 ID - Li2013 ER - TY - JOUR AU - Soh, J. W. AU - Kazi, J. U. AU - Li, H. AU - Thompson, W. J. AU - Weinstein, I. B. PY - 2008 DA - 2008// TI - Celecoxib induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G JO - Mol Carcinog VL - 47 UR - https://doi.org/10.1002/mc.20409 DO - 10.1002/mc.20409 ID - Soh2008 ER - TY - JOUR AU - Piazza, G. A. AU - Thompson, W. J. AU - Pamukcu, R. AU - Alila, H. W. AU - Whitehead, C. M. AU - Liu, L. PY - 2001 DA - 2001// TI - Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis JO - Cancer Res VL - 61 ID - Piazza2001 ER - TY - JOUR AU - Tinsley, H. N. AU - Gary, B. D. AU - Thaiparambil, J. AU - Li, N. AU - Lu, W. AU - Li, Y. PY - 2010 DA - 2010// TI - Colon tumor cell growth-inhibitory activity of sulindac sulfide and other nonsteroidal anti-inflammatory drugs is associated with phosphodiesterase 5 inhibition JO - Cancer Prev Res VL - 3 UR - https://doi.org/10.1158/1940-6207.CAPR-10-0030 DO - 10.1158/1940-6207.CAPR-10-0030 ID - Tinsley2010 ER - TY - JOUR AU - Pusztai, L. AU - Zhen, J. H. AU - Arun, B. AU - Rivera, E. AU - Whitehead, C. AU - Thompson, W. J. PY - 2003 DA - 2003// TI - Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.02.114 DO - 10.1200/JCO.2003.02.114 ID - Pusztai2003 ER - TY - JOUR AU - Whitehead, C. M. AU - Earle, K. A. AU - Fetter, J. AU - Xu, S. AU - Hartman, T. AU - Chan, D. C. AU - Zhao, T. L. PY - 2003 DA - 2003// TI - Exisulind-induced apoptosis in a non-smallcell lung cancer orthotopic lung tumor model augments docetaxeltreatment and contributes to increased survival JO - Mol Cancer Ther VL - 2 ID - Whitehead2003 ER - TY - JOUR AU - Zouaoui Boudjeltia, K. AU - Legysser, I. AU - Antwerpen, P. PY - 2006 DA - 2006// TI - Triggering of inflammatory response by myeloperoxidase-oxidized LDL JO - Biochem Cell Biol VL - 84 UR - https://doi.org/10.1139/o06-061 DO - 10.1139/o06-061 ID - Zouaoui Boudjeltia2006 ER - TY - JOUR AU - Roumeguère, T. AU - Zouaoui Boudjeltia, K. AU - Babar, S. AU - Nuyens, V. AU - Rousseau, A. AU - Antwerpen, P. PY - 2010 DA - 2010// TI - Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha JO - Eur Urol VL - 57 UR - https://doi.org/10.1016/j.eururo.2009.01.030 DO - 10.1016/j.eururo.2009.01.030 ID - Roumeguère2010 ER - TY - JOUR AU - Varma, A. AU - Das, A. AU - Hoke, N. N. AU - Durrant, D. E. AU - Salloum, F. N. AU - Kukreja, R. C. PY - 2012 DA - 2012// TI - Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0045243 DO - 10.1371/journal.pone.0045243 ID - Varma2012 ER - TY - JOUR AU - Toward, T. J. AU - Smith, N. AU - Broadley, K. J. PY - 2004 DA - 2004// TI - Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease JO - Am J Respir Crit Care Med VL - 169 UR - https://doi.org/10.1164/rccm.200211-1372OC DO - 10.1164/rccm.200211-1372OC ID - Toward2004 ER - TY - JOUR AU - El-Awady, M. S. AU - Said, E. PY - 2014 DA - 2014// TI - Vardenafil ameliorates immunologic- and non-immunologic-induced allergic reactions JO - Can J Physiol Pharmacol VL - 92 UR - https://doi.org/10.1139/cjpp-2013-0316 DO - 10.1139/cjpp-2013-0316 ID - El-Awady2014 ER - TY - JOUR AU - Medvedova, I. AU - Prso, M. AU - Eichlerova, A. AU - Mokra, D. AU - Mikolka, P. AU - Mokry, J. PY - 2015 DA - 2015// TI - Influence of roflumilast on airway reactivity and apoptosis in ovalbumin-sensitized Guinea pigs JO - Adv Exp Med Biol VL - 838 UR - https://doi.org/10.1007/5584_2014_77 DO - 10.1007/5584_2014_77 ID - Medvedova2015 ER - TY - JOUR AU - Shih, C. H. AU - Lin, L. H. AU - Hsu, H. T. AU - Wang, K. H. AU - Lai, C. Y. AU - Chen, C. M. PY - 2012 DA - 2012// TI - Hesperetin, a selective phosphodiesterase 4 inhibitor. Effectively suppresses ovalbumin-induced airway hyperresponsiveness without influencing xylazine/ketamine-induced anesthesia JO - Evid Based Complement Alternat Med VL - 2012 ID - Shih2012 ER - TY - JOUR AU - Sirad, F. AU - Hlaing, S. AU - Kovanecz, I. AU - Artaza, J. N. AU - Garcia, L. A. AU - Rajfer, J. PY - 2011 DA - 2011// TI - Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat JO - J Sex Med VL - 8 UR - https://doi.org/10.1111/j.1743-6109.2010.02195.x DO - 10.1111/j.1743-6109.2010.02195.x ID - Sirad2011 ER - TY - JOUR AU - Hlaing, S. M. AU - Garcia, L. A. AU - Kovanecz, I. AU - Martinez, R. A. AU - Shah, S. AU - Artaza, J. N. PY - 2013 DA - 2013// TI - Sildenafil promotes neuroprotection of the pelvic ganglia neurons after bilateral cavernosal nerve resection in the rat JO - BJU Int VL - 111 UR - https://doi.org/10.1111/j.1464-410X.2012.11278.x DO - 10.1111/j.1464-410X.2012.11278.x ID - Hlaing2013 ER - TY - JOUR AU - Garcia, L. A. AU - Hlaing, S. M. AU - Gutierrez, R. A. AU - Sanchez, M. D. AU - Kovanecz, I. AU - Artaza, J. N. PY - 2014 DA - 2014// TI - Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damage JO - Int J Mol Sci VL - 15 UR - https://doi.org/10.3390/ijms151017204 DO - 10.3390/ijms151017204 ID - Garcia2014 ER - TY - JOUR AU - Palmeri, A. AU - Privitera, L. AU - Giunta, S. AU - Loreto, C. PY - 2013 DA - 2013// TI - Puzzo Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory JO - Behav Brain Res VL - 240 UR - https://doi.org/10.1016/j.bbr.2012.10.060 DO - 10.1016/j.bbr.2012.10.060 ID - Palmeri2013 ER - TY - JOUR AU - Zhang, L. AU - Yu, W. AU - Schroedter, I. AU - Kong, J. AU - Vrontakis, M. PY - 2012 DA - 2012// TI - Galanin transgenic mice with elevated circulating galanin levels alleviate demyelination in a cuprizone induced MS mouse model JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0033901 DO - 10.1371/journal.pone.0033901 ID - Zhang2012 ER - TY - JOUR AU - Pifarre, P. AU - Prado, J. AU - Baltrons, M. A. AU - Giralt, M. AU - Gabarro, P. AU - Feinstein, D. L. PY - 2011 DA - 2011// TI - Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis JO - Acta Neuropathol VL - 121 UR - https://doi.org/10.1007/s00401-010-0795-6 DO - 10.1007/s00401-010-0795-6 ID - Pifarre2011 ER - TY - JOUR AU - Zhang, J. AU - Guo, J. AU - Zhao, X. AU - Chen, Z. AU - Wang, G. AU - Liu, A. PY - 2013 DA - 2013// TI - Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice JO - Behav Brain Res VL - 250 UR - https://doi.org/10.1016/j.bbr.2013.05.017 DO - 10.1016/j.bbr.2013.05.017 ID - Zhang2013 ER - TY - JOUR AU - García-Barroso, C. AU - Ricobaraza, A. AU - Pascual-Lucas, M. AU - Unceta, N. AU - Rico, A. J. AU - Goicolea, M. A. AU - Sallés, J. AU - Lanciego, J. L. AU - Oyarzabal, J. AU - Franco, R. AU - Cuadrado-Tejedor, M. AU - García-Osta, A. PY - 2013 DA - 2013// TI - Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD JO - Neuropharmacology VL - 64 UR - https://doi.org/10.1016/j.neuropharm.2012.06.052 DO - 10.1016/j.neuropharm.2012.06.052 ID - García-Barroso2013 ER - TY - JOUR AU - Alsaikhan, B. AU - Alrabeeah, K. AU - Carrier, S. PY - 2014 DA - 2014// TI - Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations JO - Int J Gen Med VL - 7 ID - Alsaikhan2014 ER - TY - JOUR AU - Kramer, G. AU - Mitteregger, D. AU - Marberger, M. PY - 2007 DA - 2007// TI - Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? JO - Eur Urol VL - 51 UR - https://doi.org/10.1016/j.eururo.2006.12.011 DO - 10.1016/j.eururo.2006.12.011 ID - Kramer2007 ER - TY - JOUR AU - Nickel, J. C. AU - Roehrborn, C. G. AU - O’Leary, M. P. AU - Bostwick, D. G. AU - Somerville, M. C. AU - Rittmaster, R. S. PY - 2008 DA - 2008// TI - The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE Trial JO - Eur Urol VL - 54 UR - https://doi.org/10.1016/j.eururo.2007.11.026 DO - 10.1016/j.eururo.2007.11.026 ID - Nickel2008 ER - TY - JOUR AU - Sciarra, A. AU - Silverio, F. AU - Salciccia, S. AU - Autran Gomez, A. M. AU - Gentilucci, A. AU - Gentile, V. PY - 2007 DA - 2007// TI - Inflammation and chronic prostatic diseases: evidence for a link? JO - Eur Urol VL - 52 UR - https://doi.org/10.1016/j.eururo.2007.06.038 DO - 10.1016/j.eururo.2007.06.038 ID - Sciarra2007 ER - TY - JOUR AU - Sarfati, M. AU - Mateo, V. AU - Baudet, S. AU - Rubio, M. AU - Fernandez, C. AU - Davi, F. PY - 2003 DA - 2003// TI - Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chroniclymphocytic leukemia cells JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-01-0075 DO - 10.1182/blood-2002-01-0075 ID - Sarfati2003 ER - TY - JOUR AU - Bang, Y. J. AU - Pirnia, F. AU - Fang, W. G. AU - Kang, W. K. AU - Sartor, O. AU - Whitesell, L. PY - 1994 DA - 1994// TI - Terminal neuroendocrine differentiationof human prostate carcinoma cells in response to increased intracellular cyclicAMP JO - Proc Natl Acad Sci U S A VL - 91 UR - https://doi.org/10.1073/pnas.91.12.5330 DO - 10.1073/pnas.91.12.5330 ID - Bang1994 ER - TY - JOUR AU - Goto, T. AU - Matsushima, H. AU - Kasuya, Y. AU - Hosaka, Y. AU - Kitamura, T. AU - Kawabe, K. PY - 1999 DA - 1999// TI - The effect of papaverine on mor-phologic differentiation, proliferation and invasive potential of human prostaticcancer LNCaP cells JO - Int J Urol VL - 6 UR - https://doi.org/10.1046/j.1442-2042.1999.00069.x DO - 10.1046/j.1442-2042.1999.00069.x ID - Goto1999 ER - TY - JOUR AU - Robert, G. AU - Smit, F. AU - Hessels, D. AU - Jannink, S. AU - Karthaus, H. F. AU - Aalders, T. PY - 2011 DA - 2011// TI - Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia JO - Prostate VL - 71 UR - https://doi.org/10.1002/pros.21387 DO - 10.1002/pros.21387 ID - Robert2011 ER - TY - JOUR AU - Adolfsson, P. I. AU - Ahlstrand, C. AU - Varenhorst, E. AU - Svensson, S. P. PY - 2002 DA - 2002// TI - Lysophosphatidicacid stimulates proliferation of cultured smooth muscle cells from human BPHtissue: sildenafil and papaverin generate inhibition JO - Prostate VL - 51 UR - https://doi.org/10.1002/pros.10077 DO - 10.1002/pros.10077 ID - Adolfsson2002 ER - TY - JOUR AU - Cook, A. L. AU - Haynes, J. M. PY - 2004 DA - 2004// TI - Protein kinase G II-mediated proliferative effects inhuman cultured prostatic stromal cells JO - Cell Signal VL - 16 UR - https://doi.org/10.1016/S0898-6568(03)00134-7 DO - 10.1016/S0898-6568(03)00134-7 ID - Cook2004 ER - TY - JOUR AU - Tinel, H. AU - Stelte-Ludwig, B. AU - Hütter, J. AU - Sandner, P. PY - 2006 DA - 2006// TI - Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms JO - BJU Int VL - 98 UR - https://doi.org/10.1111/j.1464-410X.2006.06501.x DO - 10.1111/j.1464-410X.2006.06501.x ID - Tinel2006 ER - TY - JOUR AU - Bella, A. J. AU - Deyoung, L. X. AU - Al-Numi, M. AU - Brock, G. B. PY - 2007 DA - 2007// TI - Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications JO - Eur Urol VL - 52 UR - https://doi.org/10.1016/j.eururo.2007.06.048 DO - 10.1016/j.eururo.2007.06.048 ID - Bella2007 ER - TY - JOUR AU - Wang, C. PY - 2010 DA - 2010// TI - Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia JO - Urology VL - 20 ID - Wang2010 ER - TY - JOUR AU - Fibbi, B. AU - Morelli, A. AU - Vignozzi, L. AU - Filippi, S. AU - Chavalmane, A. AU - Vita, G. PY - 2010 DA - 2010// TI - Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract JO - J Sex Med VL - 7 UR - https://doi.org/10.1111/j.1743-6109.2009.01511.x DO - 10.1111/j.1743-6109.2009.01511.x ID - Fibbi2010 ER - TY - JOUR AU - McVary, K. T. AU - Monnig, W. AU - Camps, J. L. AU - Young, J. M. AU - Tseng, L. J. AU - Ende, G. PY - 2007 DA - 2007// TI - Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial JO - J Urol VL - 177 UR - https://doi.org/10.1016/j.juro.2006.10.055 DO - 10.1016/j.juro.2006.10.055 ID - McVary2007 ER - TY - JOUR AU - Roehrborn, C. G. AU - McVary, K. T. AU - Elion-Mboussa, A. AU - Viktrup, L. PY - 2008 DA - 2008// TI - Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study JO - J Urol VL - 180 UR - https://doi.org/10.1016/j.juro.2008.06.079 DO - 10.1016/j.juro.2008.06.079 ID - Roehrborn2008 ER - TY - JOUR AU - Roehrborn, C. G. AU - Kaminetsky, J. C. AU - Auerbach, S. M. AU - Montelongo, R. M. AU - Elion-Mboussa, A. AU - Viktrup, L. PY - 2010 DA - 2010// TI - Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment JO - BJU Int VL - 105 UR - https://doi.org/10.1111/j.1464-410X.2009.08822.x DO - 10.1111/j.1464-410X.2009.08822.x ID - Roehrborn2010 ER - TY - JOUR AU - Dmochowski, R. AU - Roehrborn, C. AU - Klise, S. AU - Xu, L. AU - Kaminetsky, J. AU - Kraus, S. PY - 2010 DA - 2010// TI - Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial JO - J Urol VL - 183 UR - https://doi.org/10.1016/j.juro.2009.11.014 DO - 10.1016/j.juro.2009.11.014 ID - Dmochowski2010 ER - TY - JOUR AU - Porst, H. AU - Kim, E. D. AU - Casabé, A. R. AU - Mirone, V. AU - Secrest, R. J. AU - Xu, L. PY - 2011 DA - 2011// TI - LVHJ study team. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial JO - Eur Urol VL - 60 UR - https://doi.org/10.1016/j.eururo.2011.08.005 DO - 10.1016/j.eururo.2011.08.005 ID - Porst2011 ER - TY - JOUR AU - Oelke, M. AU - Giuliano, F. AU - Mirone, V. AU - Xu, L. AU - Cox, D. AU - Viktrup, L. PY - 2012 DA - 2012// TI - Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial JO - Eur Urol VL - 61 UR - https://doi.org/10.1016/j.eururo.2012.01.013 DO - 10.1016/j.eururo.2012.01.013 ID - Oelke2012 ER - TY - JOUR AU - Brock, G. AU - Broderick, G. AU - Roehrborn, C. G. AU - Xu, L. AU - Wong, D. AU - Viktrup, L. PY - 2013 DA - 2013// TI - Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction JO - BJU Int VL - 112 ID - Brock2013 ER - TY - JOUR AU - Cui, Y. AU - Liu, X. AU - Shi, L. AU - Gao, Z. PY - 2015 DA - 2015// TI - Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy JO - Andrologia ID - Cui2015 ER - TY - JOUR AU - Bechara, A. AU - Casabe, A. AU - Rodriguez Baigorri, G. AU - Cobreros, C. PY - 2014 DA - 2014// TI - Effectiveness of tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: results from naturalistic observational TadaLutsEd study JO - J Sex Med VL - 11 UR - https://doi.org/10.1111/jsm.12386 DO - 10.1111/jsm.12386 ID - Bechara2014 ER - TY - JOUR AU - Eryildirim, B. AU - Aktas, A. AU - Kuyumcuoglu, U. AU - Faydaci, G. AU - Tarhan, F. AU - Ozgül, A. PY - 2010 DA - 2010// TI - The effectiveness of sildenafil citrate in patients with erectile dysfunction and lower urinary system symptoms and the significance of asymptomatic inflammatory prostatitis JO - Int J Impot Res VL - 22 UR - https://doi.org/10.1038/ijir.2010.26 DO - 10.1038/ijir.2010.26 ID - Eryildirim2010 ER - TY - JOUR AU - Cantoro, U. AU - Catanzariti, F. AU - Lacetera, V. AU - Quaresima, L. AU - Muzzonigro, G. AU - Polito, M. PY - 2013 DA - 2013// TI - Comparison of tamsulosin vs tamsulosin/sildenafil effectiveness in the treatment of erectile dysfunction in patients affected by type III chronic prostatitis JO - Arch Ital Urol Androl VL - 85 UR - https://doi.org/10.4081/aiua.2013.3.109 DO - 10.4081/aiua.2013.3.109 ID - Cantoro2013 ER - TY - JOUR AU - Kaplan, S. A. AU - Gonzalez, R. R. AU - Te, A. E. PY - 2007 DA - 2007// TI - Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction JO - Eur Urol VL - 51 UR - https://doi.org/10.1016/j.eururo.2007.01.033 DO - 10.1016/j.eururo.2007.01.033 ID - Kaplan2007 ER - TY - JOUR AU - Tuncel, A. AU - Nalcacioglu, V. AU - Ener, K. AU - Aslan, Y. AU - Aydin, O. AU - Atan, A. PY - 2010 DA - 2010// TI - Sildenafil citrate and tamsulosin combination is not superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction JO - World J Urol VL - 28 UR - https://doi.org/10.1007/s00345-009-0484-z DO - 10.1007/s00345-009-0484-z ID - Tuncel2010 ER - TY - JOUR AU - Gacci, M. AU - Corona, G. AU - Salvi, M. AU - Vignozzi, L. AU - McVary, K. T. AU - Kaplan, S. A. PY - 2012 DA - 2012// TI - A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia JO - Eur Urol VL - 61 UR - https://doi.org/10.1016/j.eururo.2012.02.033 DO - 10.1016/j.eururo.2012.02.033 ID - Gacci2012 ER - TY - JOUR AU - Bechara, A. AU - Romano, S. AU - Casabé, A. AU - Haime, S. AU - Dedola, P. AU - Hernández, C. PY - 2008 DA - 2008// TI - Comparative efficacy assessment of tamsulosin vs tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study JO - J Sex Med VL - 5 UR - https://doi.org/10.1111/j.1743-6109.2008.00940.x DO - 10.1111/j.1743-6109.2008.00940.x ID - Bechara2008 ER - TY - JOUR AU - Liguori, G. AU - Trombetta, C. AU - Giorgi, G. AU - Pomara, G. AU - Maio, G. AU - Vecchio, D. PY - 2009 DA - 2009// TI - Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report JO - J Sex Med VL - 6 UR - https://doi.org/10.1111/j.1743-6109.2008.01109.x DO - 10.1111/j.1743-6109.2008.01109.x ID - Liguori2009 ER - TY - JOUR AU - Martínez-Salamanca, J. L. AU - Carballido, J. AU - Eardley, I. AU - Giuliano, F. AU - Gratzke, C. AU - Rosen, R. PY - 2011 DA - 2011// TI - Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence JO - Eur Urol VL - 60 UR - https://doi.org/10.1016/j.eururo.2011.05.054 DO - 10.1016/j.eururo.2011.05.054 ID - Martínez-Salamanca2011 ER - TY - JOUR AU - Wang, X. AU - Wang, X. AU - Li, S. AU - Meng, Z. AU - Liu, T. AU - Zhang, X. PY - 2014 DA - 2014// TI - Comparative effectiveness of oral drug therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and network meta-analysis JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0107593 DO - 10.1371/journal.pone.0107593 ID - Wang2014 ER - TY - JOUR AU - Gomes, F. O. AU - Carvalho, M. C. AU - Saraiva, K. L. AU - Ribeiro, E. L. AU - E Silva, A. K. AU - Donato, M. A. PY - 2014 DA - 2014// TI - Effect of chronic Sildenafil treatment on the prostate of C57Bl/6 mice JO - Tissue Cell VL - 46 UR - https://doi.org/10.1016/j.tice.2014.08.001 DO - 10.1016/j.tice.2014.08.001 ID - Gomes2014 ER - TY - JOUR AU - Hammarsten, J. AU - Peeker, R. PY - 2011 DA - 2011// TI - Urological aspects of the metabolic syndrome JO - Nat Rev Urol VL - 8 UR - https://doi.org/10.1038/nrurol.2011.112 DO - 10.1038/nrurol.2011.112 ID - Hammarsten2011 ER - TY - JOUR AU - Morelli, A. AU - Filippi, S. AU - Comeglio, P. AU - Sarchielli, E. AU - Chavalmane, A. K. AU - Vignozzi, L. PY - 2010 DA - 2010// TI - Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats JO - J Sex Med VL - 7 UR - https://doi.org/10.1111/j.1743-6109.2009.01558.x DO - 10.1111/j.1743-6109.2009.01558.x ID - Morelli2010 ER - TY - JOUR AU - Morelli, A. AU - Sarchielli, E. AU - Comeglio, P. AU - Filippi, S. AU - Mancina, R. AU - Gacci, M. PY - 2011 DA - 2011// TI - Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats JO - J Sex Med VL - 8 UR - https://doi.org/10.1111/j.1743-6109.2011.02416.x DO - 10.1111/j.1743-6109.2011.02416.x ID - Morelli2011 ER - TY - JOUR AU - Zarifpour, M. AU - Nomiya, M. AU - Sawada, N. AU - Andersson, K. E. PY - 2015 DA - 2015// TI - Protective effect of tadalafil on the functional and structural changes of the rat ventral prostate caused by chronic pelvic ischemia JO - Prostate VL - 75 UR - https://doi.org/10.1002/pros.22909 DO - 10.1002/pros.22909 ID - Zarifpour2015 ER - TY - JOUR AU - McVary, K. T. PY - 2006 DA - 2006// TI - Unexpected insights into pelvic function following phosphodiesterase manipulation—what’s next for urology? JO - Eur Urol VL - 50 UR - https://doi.org/10.1016/j.eururo.2006.09.014 DO - 10.1016/j.eururo.2006.09.014 ID - McVary2006 ER - TY - JOUR AU - Ozden, C. AU - Ozdal, O. L. AU - Urgancioglu, K. H. AU - Gokkaya, S. AU - Memis, A. PY - 2007 DA - 2007// TI - The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia JO - Eur Urol VL - 51 UR - https://doi.org/10.1016/j.eururo.2006.05.040 DO - 10.1016/j.eururo.2006.05.040 ID - Ozden2007 ER - TY - JOUR AU - Nunzio, C. AU - Aronson, W. AU - Freedland, S. J. AU - Giovannucci, E. AU - Parsons, J. K. PY - 2012 DA - 2012// TI - The correlation between metabolic syndrome and prostatic diseases JO - Eur Urol VL - 61 UR - https://doi.org/10.1016/j.eururo.2011.11.013 DO - 10.1016/j.eururo.2011.11.013 ID - Nunzio2012 ER - TY - JOUR AU - Morelli, A. AU - Filippi, S. AU - Sandner, P. AU - Fibbi, B. AU - Chavalmane, A. K. AU - Silvestrini, E. PY - 2009 DA - 2009// TI - Vardenafil modulates bladder contractility through cGMPmediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats JO - J Sex Med VL - 6 UR - https://doi.org/10.1111/j.1743-6109.2009.01249.x DO - 10.1111/j.1743-6109.2009.01249.x ID - Morelli2009 ER - TY - JOUR AU - Chang, S. AU - Hypolite, J. A. AU - Changolkar, A. AU - Wein, A. J. AU - Chacko, S. AU - DiSanto, M. E. PY - 2003 DA - 2003// TI - Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta JO - Int J Impot Res VL - 15 UR - https://doi.org/10.1038/sj.ijir.3900947 DO - 10.1038/sj.ijir.3900947 ID - Chang2003 ER - TY - JOUR AU - Bivalacqua, T. J. AU - Champion, H. C. AU - Usta, M. F. AU - Cellek, S. AU - Chitaley, K. AU - Webb, R. C. PY - 2004 DA - 2004// TI - RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction JO - Proc Natl Acad Sci U S A VL - 101 UR - https://doi.org/10.1073/pnas.0400520101 DO - 10.1073/pnas.0400520101 ID - Bivalacqua2004 ER - TY - JOUR AU - Vignozzi, L. AU - Morelli, A. AU - Filippi, S. AU - Ambrosini, S. AU - Mancina, R. AU - Luconi, M. PY - 2007 DA - 2007// TI - Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes JO - J Sex Med VL - 4 UR - https://doi.org/10.1111/j.1743-6109.2007.00440.x DO - 10.1111/j.1743-6109.2007.00440.x ID - Vignozzi2007 ER - TY - JOUR AU - Lythgoe, C. AU - McVary, K. T. PY - 2013 DA - 2013// TI - The use of PDE-5 inhibitors in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia JO - Curr Urol Rep VL - 14 UR - https://doi.org/10.1007/s11934-013-0373-2 DO - 10.1007/s11934-013-0373-2 ID - Lythgoe2013 ER - TY - JOUR AU - Vignozzi, L. AU - Gacci, M. AU - Cellai, I. AU - Morelli, A. AU - Maneschi, E. AU - Comeglio, P. PY - 2013 DA - 2013// TI - PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS JO - Prostate VL - 73 UR - https://doi.org/10.1002/pros.22686 DO - 10.1002/pros.22686 ID - Vignozzi2013 ER -